SCHEMBL25834681

SCHEMBL25834681

Cc1ccc([C@@]2(O)C(=O)c3ccccc3C(=O)[C@@H]2O)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
MAPT P10636 6/20 0.45
CYP1A2 P05177 1/20 0.45
CYP2C9 P11712 1/20 0.45
CYP2C19 P33261 1/20 0.45
ALDH1A1 P00352 5/20 0.41
L3MBTL1 Q9Y468 3/20 0.41
RECQL P46063 3/20 0.41
CA1 P00915 2/20 0.41
CA2 P00918 2/20 0.41
CA7 P43166 2/20 0.41
CA9 Q16790 2/20 0.41
ALOX12 P18054 2/20 0.41
TSHR P16473 1/20 0.41
MAPK1 P28482 1/20 0.41
CASP1 P29466 1/20 0.41
BACE1 P56817 1/20 0.41
EHMT2 Q96KQ7 1/20 0.41
GFER P55789 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25834356 1.00 MEN1 (0.46) MEN1KMT2AMAPTCYP1A2CYP2C9
SCHEMBL25834638 0.88 ALDH1A1 (0.45) MEN1KMT2AMAPTCYP1A2ALDH1A1
SCHEMBL25834688 0.86 MEN1 (0.45) MEN1KMT2AMAPTALDH1A1L3MBTL1
SCHEMBL25835315 0.86 MEN1 (0.45) MEN1KMT2AMAPTALDH1A1L3MBTL1
SCHEMBL25834684 0.85 MAPT (0.51) MEN1KMT2AMAPTCYP2C9CYP2C19
SCHEMBL25835314 0.85 MAPT (0.51) MEN1KMT2AMAPTCYP2C9CYP2C19
SCHEMBL25835335 0.82 MAPT (0.48) KMT2AMAPTALDH1A1L3MBTL1RECQL
SCHEMBL25834779 0.82 MAPT (0.48) KMT2AMAPTALDH1A1L3MBTL1RECQL
SCHEMBL10584320 0.78 ALDH1A1 (0.48) MEN1KMT2AMAPTCYP1A2CYP2C9
SCHEMBL25834634 0.78 ALDH1A1 (0.48) MEN1KMT2AMAPTCYP1A2CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230227393-A1 IRON CATALYZED HIGHLY ENANTIOSELECTIVE CIS-DIHYDROXYLATION OF QUINONES THE UNIVERSITY OF HONG KONG (CN) 2023-07-20 US disclosed
US-20230227393-A1 IRON CATALYZED HIGHLY ENANTIOSELECTIVE CIS-DIHYDROXYLATION OF QUINONES THE UNIVERSITY OF HONG KONG (CN) 2023-07-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230227393-A1 IRON CATALYZED HIGHLY ENANTIOSELECTIVE CIS-DIHYDROXYLATION OF QUINONES NFE2L2, DUOX1, DUOX2 MEN1 1455/4885KMT2A 1287/4885MAPT 736/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.